1-3 of 3
Daniel E.H. Afar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B231: Targeting Her2+ ductal breast cancer with PDL192, a novel humanized anti‐TweakR monoclonal antibody

Debra T. Chao, Mien Su, Mien Sho, Doghee Choi, Shiming Ye, Sonia Tomlinco, Han Kim, Yongke Zhang, Johnny Yin, Eric D. Hsi, Lisa Durkan, Peter Lambert, Gary C. Starling, Daniel E.H. Afar, Patricia A. Culp
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B231.
https://doi.org/10.1158/1535-7163.TARG-09-B231
Published: 10 December 2009
View articletitled, Abstract B231: Targeting Her2+ ductal breast cancer with PDL192, a novel humanized anti‐TweakR monoclonal antibody
Journal Articles

Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma

Frits van Rhee, Susann M. Szmania, Myles Dillon, Anne M. van Abbema, Xin Li, Mary K. Stone, Tarun K. Garg, JuMei Shi, Amberly M. Moreno-Bost, Rui Yun, Balaji Balasa, Bishwa Ganguly, Debra Chao, Audie G. Rice, Fenghuang Zhan, John D. Shaughnessy, Jr., Bart Barlogie, Shmuel Yaccoby, Daniel E.H. Afar
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (9): 2616–2624.
https://doi.org/10.1158/1535-7163.MCT-09-0483
Published: 17 September 2009
View articletitled, Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
Open the PDF for Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma in another window
Includes: Supplementary data
Journal Articles

Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

Daniel E.H. Afar, Vinay Bhaskar, Eric Ibsen, Danna Breinberg, Susan M. Henshall, James G. Kench, Marija Drobnjak, Rick Powers, Melanie Wong, Ferdinand Evangelista, Chris O'Hara, David Powers, Robert B. DuBridge, Ingrid Caras, Ruth Winter, Terri Anderson, Nanette Solvason, Phillip D. Stricker, Carlos Cordon-Cardo, Howard I. Scher, John J. Grygiel, Robert L. Sutherland, Richard Murray, Vanitha Ramakrishnan, Debbie A. Law
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (8): 921–932.
https://doi.org/10.1158/1535-7163.921.3.8
Published: 06 August 2004
View articletitled, Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer
Open the PDF for Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer in another window